SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-21-016535
Filing Date
2021-01-26
Accepted
2021-01-25 17:57:58
Documents
1
Group Members
VERSANT DEVELOPMENT FUND III, LLCVERSANT SIDE FUND III, L.P.VERSANT VENTURES III, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d117972dsc13da.htm SC 13D/A 81706
  Complete submission text file 0001193125-21-016535.txt   83373
Mailing Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803
Business Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 (781) 305-7777
Flexion Therapeutics Inc (Subject) CIK: 0001419600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88031 | Film No.: 21551048
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104 650-233-2211
Versant Venture Capital III, L.P. (Filed by) CIK: 0001456586 (see all company filings)

IRS No.: 203659276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A